Trial title not recorded
Viremia · Bacteremia · Acute Rejection of Renal Transplant
Enrolment: 40 · Results not recorded
Loading the evidence…
Biologic · ChEMBL mechanism record: replacement therapy with immunomodulatory effects (EMA Privigen EPAR). No single molecular target assigned. Black box warning present; approved 2006.
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Viremia · Bacteremia · Acute Rejection of Renal Transplant
Enrolment: 40 · Results not recorded
Kidney Transplantation
Enrolment: 18 · Results not recorded
Primary Immune Deficiency Disorders · Common Variable Immunodeficiency · X-linked Agammaglobulinaemia · Hyper-IgM Syndrome
Enrolment: 48 · Results not recorded
Immune Thrombocytopenia (ITP)
Enrolment: 272 · Results not recorded
Motor Neuron Disease
Enrolment: 23 · Results not recorded
Post-polio Syndrome
Enrolment: 191 · Results not recorded
Pemphigus
Enrolment: 20 · Results not recorded
Primary Immunodeficiency
Enrolment: 60 · Results not recorded
Hypogammaglobulinemia, Acquired
Enrolment: 30 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Moderate-severe clip compression-contusion cervical spinal cord injury using a 35 g modified aneurysm clip applied extradurally at the C7-T1 level for 60 seconds
A single intravenous bolus of hIgG at 2 g/kg given 15 min after cervical clip compression injury increased tight junction protein expression, lowered active MMP-9, reduced neutrophil infiltration and myeloperoxidase activity, and improved functional blood flow while reducing acute lesion volume. Th…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.